ivermectin oral / Generic mfg. 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 


«12...979899100101102103104105106107...129130»
  • ||||||||||  ivermectin / Generic mfg.
    Journal:  Resistance of the cattle tick Rhipicephalus (Boophilus) microplus to ivermectin in Argentina. (Pubmed Central) -  Dec 31, 2020   
    The population "San Martín" was classified in the category "incipient resistant" with LIT analysis, but the field trial unambiguously shows that this tick population is resistant. The comparison of the results obtained with LIT in vitro assays and through field trials shows that biased estimations of resistance levels may occur when resistance ratios (RR) values are ≤2, and additional field efficacy trials could be needed to know with precision the status of the tick populations evaluated.
  • ||||||||||  ivermectin / Generic mfg.
    Review, Journal:  Ivermectin: An Anthelmintic, an Insecticide, and Much More. (Pubmed Central) -  Dec 31, 2020   
    In addition, in tissue culture, at concentrations higher than anthelmintic concentrations, ivermectin shows antiviral, antimalarial, antimetabolic, and anticancer effects. Caution is required before extrapolating from these preliminary repositioning experiments to clinical use, particularly for Covid-19 treatment, because of the high concentrations of ivermectin used in tissue-culture experiments.
  • ||||||||||  Actemra IV (tocilizumab) / Roche, JW Pharma
    FDA event, Review, Journal:  FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy. (Pubmed Central) -  Dec 30, 2020   
    We discuss a number of other drugs that are currently in clinical trials, whose results are not yet available, and in various instances we enrich such efficacy analysis by invoking historic data on the treatment of SARS, MERS, influenza, or in vitro studies. Meanwhile, scientists worldwide are seeking to discover novel drugs that take advantage of the molecular structure of the virus, its intracellular life cycle that probably elucidates unfolded-protein response, as well as its mechanism of surface binding and cell invasion, like angiotensin converting enzymes-, HR1, and metalloproteinase inhibitors.
  • ||||||||||  ivermectin / Generic mfg.
    Journal:  Antiviral and Anti-Inflammatory Properties of Ivermectin and Its Potential Use in Covid-19. (Pubmed Central) -  Dec 30, 2020   
    Meanwhile, scientists worldwide are seeking to discover novel drugs that take advantage of the molecular structure of the virus, its intracellular life cycle that probably elucidates unfolded-protein response, as well as its mechanism of surface binding and cell invasion, like angiotensin converting enzymes-, HR1, and metalloproteinase inhibitors. No abstract available
  • ||||||||||  Journal:  The P-glycoprotein repertoire of the equine parasitic nematode Parascaris univalens. (Pubmed Central) -  Dec 30, 2020   
    Expression and functional analyses of PunPgp-2 and PunPgp-9 in Saccharomyces cerevisiae provide evidence for an interaction with ketoconazole and ivermectin, but not thiabendazole. Overall, this study established reliable reference gene models with significantly improved annotation for the P. univalens Pgp repertoire and provides a foundation for a better understanding of Pgp-mediated anthelmintic resistance.
  • ||||||||||  ivermectin / Generic mfg.
    Journal:  High morbidity cutaneous enzootic myiasis by Dermatobia hominis (Diptera: Oestridae) in sambar deer (Rusa unicolor). (Pubmed Central) -  Dec 30, 2020   
    The systemic treatment with oral ivermectin at 0.08% was effective in 93.7% of deer with enzootic cutaneous myiasis after fourteen days...Sambar deer was the only species affected by D. hominis, even though several other wild herbivores were kept in the same area. More studies are needed to elucidate the susceptibility of R. unicolor to D. hominis cutaneous infestations.
  • ||||||||||  ivermectin / Generic mfg.
    Clinical, Clinical protocol, Observational data, Retrospective data, Review, Journal:  Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19. (Pubmed Central) -  Dec 30, 2020   
    More studies are needed to elucidate the susceptibility of R. unicolor to D. hominis cutaneous infestations. No abstract available